Literature DB >> 6778219

The pathology of the feline model of mucopolysaccharidosis VI.

M E Haskins, G D Aguirre, P F Jezyk, D F Patterson.   

Abstract

Three cats with feline arylsulfatase-B--deficient mucopolysaccharidosis were studied by light and transmission electron microscopy. Membrane-bound cytoplasmic inclusions were present in hepatocytes, bone marrow granulocytes, vascular smooth muscle cells, and fibroblasts in skin, cornea, and cardiac valves. Central nervous system lesions were restricted to mild ventricular dilatation, perithelial cell vacuolation, and, in one animal, cord compression by vertebral exostoses. The lesions in these cats closely resembled those described in human patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778219      PMCID: PMC1903664     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Histochemical and electron microscopic study in a case of Hurler's disease.

Authors:  D LAGUNOFF; R ROSS; E P BENDITT
Journal:  Am J Pathol       Date:  1962-09       Impact factor: 4.307

2.  Ultrastructure of cartilage in the Hurler and Sanfilippo syndromes.

Authors:  R Silberberg; D L Rimoin; R E Rosenthal; M B Hasler
Journal:  Arch Pathol       Date:  1972-12

3.  A histopathologic study of the heart in gargoylism.

Authors:  R Okada; I M Rosenthal; G Scaravelli; M Lev
Journal:  Arch Pathol       Date:  1967-07

4.  Myelopathy associated with Maroteaux-Lamy syndrome.

Authors:  D I Peterson; H Bacchus; L Seaich; T E Kelly
Journal:  Arch Neurol       Date:  1975-02

5.  Glycosaminoglycans and endochondral calcification.

Authors:  B De Bernard; N Stagni; I Colautti; F Vittur; E Bonucci
Journal:  Clin Orthop Relat Res       Date:  1977 Jul-Aug       Impact factor: 4.176

6.  Mucopolysaccharidosis VI (Maroteaux-Lamy's disease).

Authors:  J W Spranger; F Koch; V A McKusick; J Natzschka; H R Wiedemann; H Zellweger
Journal:  Helv Paediatr Acta       Date:  1970-10

7.  Ocular pathology of the Maroteaux-Lamy syndrome (systemic mucopolysaccharidosis type VI). Histologic and ultrastructural report of two cases.

Authors:  K R Kenyon; T M Topping; W R Green; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1972-05       Impact factor: 5.258

8.  Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.

Authors:  A S Dekaban; G Constantopoulos
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

9.  Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome.

Authors:  P F Jezyk; M E Haskins; D F Patterson; W J Mellman; M Greenstein
Journal:  Science       Date:  1977-11-25       Impact factor: 47.728

10.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02
View more
  21 in total

1.  Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

Authors:  A C Crawley; K H Niedzielski; E L Isaac; R C Davey; S Byers; J J Hopwood
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Altered olfactory epithelial structure and function in feline models of mucopolysaccharidoses I and VI.

Authors:  Fritz W Lischka; George Gomez; Karen K Yee; Luba Dankulich-Nagrudny; Leen Lo; Mark E Haskins; Nancy E Rawson
Journal:  J Comp Neurol       Date:  2008-11-20       Impact factor: 3.215

3.  Animal models for lysosomal storage diseases: a new case of feline mucopolysaccharidosis VI.

Authors:  P Di Natale; T Annella; A Daniele; G Spagnuolo; R Cerundolo; D de Caprariis; A E Gravino
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

Authors:  A C Crawley; D A Brooks; V J Muller; B A Petersen; E L Isaac; J Bielicki; B M King; C D Boulter; A J Moore; N L Fazzalari; D S Anson; S Byers; J J Hopwood
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

5.  Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats.

Authors:  Katherine P Ponder; Thomas M O'Malley; Ping Wang; Patricia A O'Donnell; Anne M Traas; Van W Knox; Gustavo A Aguirre; N Matthew Ellinwood; Jason A Metcalf; Bin Wang; Emma J Parkinson-Lawrence; Meg M Sleeper; Doug A Brooks; John J Hopwood; Mark E Haskins
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

6.  Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I.

Authors:  R M Shull; R J Munger; E Spellacy; C W Hall; G Constantopoulos; E F Neufeld
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

7.  Retarded bone formation in GM1-gangliosidosis: a study of the infantile form and comparison with two canine models.

Authors:  J Alroy; K Knowles; S H Schelling; E M Kaye; A E Rosenberg
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Morphologic and biochemical studies of canine mucopolysaccharidosis I.

Authors:  R M Shull; R G Helman; E Spellacy; G Constantopoulos; R J Munger; E F Neufeld
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

9.  Arylsulfatase B-deficient mucopolysaccharidosis in rats.

Authors:  M Yoshida; J Noguchi; H Ikadai; M Takahashi; S Nagase
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Animal model of human disease: Mucopolysaccharidosis VI Maroteaux-Lamy syndrome, Arylsulfatase B-deficient mucopolysaccharidosis in the Siamese cat.

Authors:  M E Haskins; P F Jezyk; R J Desnick; D F Patterson
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.